Xabier Garcia de Albeniz Martinez

RTI Health Solutions
Harvard T.H. Chan School of Public Health, Spain

Poster(s):

• (55) Daily Tenofovir Disoproxil Fumarate/Emtricitabine and Hydroxychloroquine for Pre-Exposure Prophylaxis of COVID-19: A Double-Blind Placebo Controlled Randomized Trial in Healthcare Workers. A Randomized Clinical Trial
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (56) Drug Repurposing in a Pandemic: Systematic Review and Meta-Analysis of Randomized Trials of Hydroxychloroquine for the Prevention of COVID-19. What Have We Learned?
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (148) The Effect of Continuous Use of Antidepressants, with or Without Anticholinergic Properties, for At Least 4 Months Versus No Treatment on The Incidence of Dementia: A Target Trial Emulation
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (301) VAC4EU Active Safety Surveillance Study of The BNT162b2 COVID-19 Vaccine in Five European Countries: Study Design and First Results
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST